High Frequency and Poor Prognosis of Late Childhood BCR-ABL-Positive and MLL-AF4-Positive ALL Define the Need for Advanced Molecular Diagnostics and Improved Therapeutic Strategies in Pediatric B-ALL in Pakistan-Reference-Cited by-同舟云学术

High Frequency and Poor Prognosis of Late Childhood BCR-ABL-Positive and MLL-AF4-Positive ALL Define the Need for Advanced Molecular Diagnostics and Improved Therapeutic Strategies in Pediatric B-ALL in Pakistan

Published:2015-08-13 Issue:5 Volume:19 Page:277-287
ISSN:1177-1062
Container-title:Molecular Diagnosis & Therapy
language:en
Short-container-title:Mol Diagn Ther

Author:

Iqbal Zafar,Akhtar Tanveer,Awan Tashfin,Aleem Aamer,Sabir Noreen,Rasool Mahmood,Absar Muhammad,Akram Afia M.,Shammas Masood A.,Shah Ijaz H.,Khalid Muhammad,Taj Abid S.,Jameel Abid,Alanazi Abdullah,Gill Ammara T.,Hashmi Jamil Amjad,Hussain Akhtar,Sabar Muhammad Farooq,Khalid Ahmad M.,Qazi Mehmood Hussain,Karim Sajjad,Siddiqi Muhammad Hassan,Mahmood Aamir,Iqbal Mudassar,Saeed Anjum,Irfan Muhammad Imran

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40291-015-0149-0.pdf

Reference59 articles.

1. Annesley CE, Brown P. Novel agents for the treatment of childhood acute leukemia. Ther Adv Hematol. 2015;6(2):61–79.

2. McNally RJ, Alston RD, Cairns DP, Eden OB, Birch JM. Geographical and ecological analyses of childhood acute leukaemias and lymphomas in north-west England. Br J Haematol. 2003;123:60–5.

3. Iacobucci I, Papayannidis C, Lonetti A, Ferrari A, Baccarani M, et al. Cytogenetic and molecular predictors of outcome in acute lymphocytic leukemia: recent developments. Curr Hematol Malig Rep. 2012;7:133–43.

4. Xu H, Cheng C, Devidas M, Pei D, Fan Y, et al. ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol. 2012;30:751–7.

5. Mullighan CG. Genomic characterization of childhood acute lymphoblastic leukemia. Semin Hematol. 2013;50(4):314–24.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of diagnostic efficacy of NRP‐1/CD304 in hematological diseases;Cancer Medicine;2023-03-25

2. Treatment outcomes and prognostic factors of childhood acute lymphoblastic leukemia in a low–middle income population: A multi‐institutional report from Pakistan;Pediatric Blood & Cancer;2022-08-03

3. Impact of Consolidative Unrelated Cord Blood Transplantation on Clinical Outcomes of Patients With Relapsed/Refractory Acute B Lymphoblastic Leukemia Entering Remission Following CD19 Chimeric Antigen Receptor T Cells;Frontiers in Immunology;2022-04-26

4. Anti‐CD19 chimeric antigen receptor‐modified T‐cell therapy bridging to allogeneic hematopoietic stem cell transplantation for relapsed/refractory B‐cell acute lymphoblastic leukemia: An open‐label pragmatic clinical trial;American Journal of Hematology;2019-08-02